Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000533650 | SCV000645527 | benign | Alagille syndrome due to a JAG1 point mutation | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491063 | SCV002781640 | uncertain significance | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2021-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024061 | SCV003951735 | uncertain significance | Cardiovascular phenotype | 2023-03-31 | criteria provided, single submitter | clinical testing | The c.2827C>T (p.P943S) alteration is located in exon 23 (coding exon 23) of the JAG1 gene. This alteration results from a C to T substitution at nucleotide position 2827, causing the proline (P) at amino acid position 943 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |